Skip to content
    • +1 (888) 485-6340
  • Home
  • Contact Us
  • Sign Up for Email Alert
  • Careers
  • TSX-V:BCT: (%)
  • NASDAQ:BCTX: (%)
BriacellBriacell
  • Generic selectors
    Exact matches only
    Search in title
    Search in content
    Search in posts
    Search in pages
  • About Us
    • About Briacell
    • Board of Directors
    • Management
    • Scientific Advisory Board
    • Business Development
    • Privacy Policy
  • Technology
    • Bria-IMT™
    • Bria-OTS™
    • BriaDX™
    • PKCδ
    • Patents
    • Mechanism of Action of Bria-IMT™ and Bria-OTS™
    • Clinical Trials
    • Scientific Publications
  • In the News
    • Recent News
    • Recent Media
  • Investor Relations
    • Corporate Profile
    • Presentations
    • Corporate Governance
    • News and Events
    • Filings
    • Shareholder Information
    • FAQ
    • Email Alerts
    • Contact Us
News and Events, Recent Events, Recent News

Recording of The Webinar: BriaCell Therapeutics Corporate Update – June 28, 2018

Posted on June 27, 2018March 14, 2019 by Farrah Dean

To listen to the Webinar, please kindly click on the following link:

http://cc.readytalk.com/play?id=fvx4z8

This entry was posted in News and Events, Recent Events, Recent News. Bookmark the permalink.
BriaCell to Hold Conference Call on Key Clinical Findings; Activities
BriaCell Adds New Clinical Site To Phase IIa Study in Advanced Breast Cancer and Expands R&D Team
Recent News
  • BriaCell Therapeutics to Present at the American Association for Cancer Research Annual Meeting 2021 March 30, 2021
  • BriaCell Announces Closing of US$25 Million Public Offering February 26, 2021
  • BriaCell Announces Pricing of US$25 Million Public Offering and Nasdaq Listing February 23, 2021
  • BriaCell Presents Clinical Data at 2021 Keystone Symposium January 26, 2021
  • BriaCell Announces Presentation at the 2021 Keystone Symposia Conference: Emerging Cell Therapies January 12, 2021
Categories
  • Annual Reports
  • News and Events
    • Recent Events
    • Recent News
Archives
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • November 2015
  • October 2015
  • September 2015
  • July 2015
  • June 2015
  • November 2014
  • April 2014

Corporate Office- Canada
Suite 300 - Bellevue Centre
235 -15th Street
West Vancouver, BC V7T 2X1
Tel: 604-921-1810
Fax: 604-921-1898

Corporate Office- US
820 Heinz Avenue
Berkeley, CA, 94710
Tel: 1-888-485-6340
Fax: 424-245-3719

About Us
  • About Briacell
  • Board of Directors
  • Management
  • Scientific Advisory Board
  • Business Development
  • Privacy Policy
Technology
  • Bria-IMT™
  • Bria-OTS™
  • BriaDX™
  • PKCδ
  • Patents
  • Mechanism of Action of Bria-IMT™ and Bria-OTS™
  • Clinical Trials
  • Scientific Publications
Investor Relations
  • Corporate Profile
  • Presentations
  • Corporate Governance
  • News and Events
  • Filings
  • Shareholder Information
  • FAQ
  • Email Alerts
  • Contact Us

Signup for our Email Alert!


Copyright 2021 © Briacell.| All rights reserved | XML Sitemap | HTML Sitemap
  • About Us
    • About Briacell
    • Board of Directors
    • Management
    • Scientific Advisory Board
    • Business Development
    • Privacy Policy
  • Technology
    • Bria-IMT™
    • Bria-OTS™
    • BriaDX™
    • PKCδ
    • Patents
    • Mechanism of Action of Bria-IMT™ and Bria-OTS™
    • Clinical Trials
    • Scientific Publications
  • In the News
    • Recent News
    • Recent Media
  • Investor Relations
    • Corporate Profile
    • Presentations
    • Corporate Governance
    • News and Events
    • Filings
    • Shareholder Information
    • FAQ
    • Email Alerts
    • Contact Us
  • Home
  • Contact Us
  • Sign Up for Email Alert
  • Careers
  • TSX-V:BCT: (%)
  • NASDAQ:BCTX: (%)